Skip to main content
BioTelemetry announces completion of $280M LifeWatch acquisition
7/14/2017

The acquisition of remote cardiac monitoring company LifeWatch has been completed by BioTelemetry in a cash-and-stock deal worth $280 million. The company plans to expand into other areas of chronic care and "advance device innovation."

Full Story: